NVIDIA expands healthcare AI push with protein design and radiotherapy
NVIDIA announced healthcare and life sciences collaborations on protein design, scientific agents and adaptive radiotherapy at GTC Berlin on Oct. 21, 2026.
Anthropic says Claude designed binders for scorpion neurotoxins
Anthropic says Claude helped design 211 minibinders against scorpion neurotoxins, with 17 meeting binding criteria in lab tests.
NVIDIA BioNeMo Toolkit Accelerates AI-Driven Drug Discovery
NVIDIA's BioNeMo Agent Toolkit boosts AI-powered co-folding, enabling faster drug discovery and large-scale protein modeling.
NVIDIA BioNeMo Toolkit Powers AI Agents in Life Sciences
NVIDIA's BioNeMo Agent Toolkit integrates with Anthropic's Claude Science, offering accelerated AI workflows for life sciences research.
NVIDIA BioNeMo Toolstream Turns AI into Life Science Researchers
NVIDIA's BioNeMo Agent Toolkit enables autonomous AI-driven biomolecular research, accelerating drug discovery and biological modeling.
AI-Powered Chemist GPT-5.4 Boosts Drug Reaction Yields
OpenAI's GPT-5.4 improves a key drug-making reaction, enhancing efficiency in medicinal chemistry and advancing AI's role in scientific discovery.
OpenAI Expands GPT-Rosalind Capabilities for Life Sciences
OpenAI enhances GPT-Rosalind with advanced biological reasoning, boosting drug discovery and genomics workflows for enterprise research.
IBM Releases Quantum-HPC Integration Blueprint Targeting Drug Discovery
IBM publishes reference architecture for embedding quantum processors into existing supercomputing centers, enabling molecular simulations beyond classical capabilities.
NVIDIA Survey Shows 70% of Healthcare Firms Now Deploy AI as ROI Hits Mainstream
NVIDIA's 2026 healthcare AI survey reveals adoption jumped to 70% from 63%, with 85% of executives reporting revenue gains and nearly half planning 10%+ budget increases.
Lilly Unveils Groundbreaking AI Factory for Drug Discovery with NVIDIA's DGX SuperPOD
Lilly has launched the largest AI factory in the pharmaceutical sector, leveraging NVIDIA's DGX SuperPOD to revolutionize drug discovery and personalized medicine.